Latest filing published 04 Apr 2022 for Neogenomics INC.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Douglas Matthew Brown: trading record in brief
Douglas Matthew Brown (chief executive) discloses dealings in Neogenomics Inc to SEC (Form 4). Between 2 March 2021 and 1 April 2022, the trades on record add up to 8 filings.
The open-market record consists of 3 sales worth €3.3M, with no purchase. Other entries cover 5 share grants.
The latest filing, published on 4 April 2022, reports a share grant in Neogenomics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Douglas Matthew Brown
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 82,305 shares0Common StockSEC:0001077183-22-000054:0
- 35,030 shares0Common StockSEC:0001077183-22-000039:0
- 30,572 shares0Common StockSEC:0001077183-21-000271:0
- 33,333 shares@ US$37.19100.0% of flowCommon StockSEC:0001077183-21-000249:0
4 of 4 declarations
